Internal Medicine, Medical Oncology · San Jose, CA
NPI
1871777573
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2589 Samaritan Dr
San Jose, CA, 95124
Phone (650) 498-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,271
36 services
Medicare patients, 2024
27
Average age 76
Drug cost, 2024
$3.0M
557 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Teja Bedi was code 99214 (office e&m - established), 12 times for 11 patients. In total Teja Bedi billed 36 services in 11 codes, and Medicare paid $4,271.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 12 | 11 | $107.85 | $1,294 |
Medicare prescription drug claims, 2024
In 2024, the drug Teja Bedi prescribed most often to Medicare patients was Anastrozole, with 69 prescriptions and refills. In total Teja Bedi wrote 557 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 69 | 126 | 15 | $7,171 |
| Imbruvica Ibrutinib | 27 | 27 | Under 11 | $441K |
| Omeprazole Generic | 25 | 31 | Under 11 | $265 |
| Bosulif Bosutinib | 23 | 23 | Under 11 | $451K |
| Hydroxyurea Generic | 22 | 31 | Under 11 | $242 |
| Eliquis Apixaban | 21 | 29 | Under 11 | $17K |
| Xtandi Enzalutamide | 19 | 19 | Under 11 | $305K |
| Sprycel Dasatinib | 18 | 18 | Under 11 | $329K |
| Famotidine Generic | 18 | 30 | Under 11 | $281 |
| Ondansetron Hcl Generic | 17 | 17 | Under 11 | $253 |
| Alecensa Alectinib Hcl | 16 | 16 | Under 11 | $273K |
| Dexamethasone Generic | 15 | 15 | Under 11 | $474 |
| Alendronate Sodium Generic | 14 | 30 | Under 11 | $148 |
| Imatinib Mesylate Generic | 14 | 14 | Under 11 | $1,747 |
| Piqray Alpelisib | 13 | 14 | Under 11 | $294K |
Brand drugs: - claims; generic drugs: 342 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Teja Bedi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.